tiprankstipranks
Trending News
More News >
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market

Aligos Therapeutics (ALGS) Income Statement

Compare
202 Followers

Aligos Therapeutics Income Statement

Last quarter (Q4 2024), Aligos Therapeutics's total revenue was $629.00K, a decrease of -76.54% from the same quarter last year. In Q4, Aligos Therapeutics's net income was $-82.15M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.94M$ 15.53M$ 13.91M$ 4.36M$ 0.00
Gross Profit
$ 3.94M$ 12.46M$ 10.23M$ -99.79M$ -3.33M
Operating Expenses
$ 93.10M$ 103.66M$ 111.49M$ 132.68M$ 97.83M
Depreciation and Amortization
$ 0.00$ 3.07M$ 3.67M$ 3.78M$ 3.33M
EBITDA
$ -89.15M$ -85.06M$ -93.91M$ -124.54M$ -105.06M
Operating Income
$ -89.15M$ -88.13M$ -97.58M$ -128.32M$ -97.83M
Other Income/Expenses
$ -41.73M$ 1.24M$ 1.64M$ 132.00K$ -10.55M
Pretax Income
$ -130.88M$ -86.88M$ -95.94M$ -128.19M$ -108.38M
Net Income
$ -131.21M$ -87.68M$ -96.05M$ -128.33M$ -108.54M
Per Share Metrics
Basic EPS
$ -20.94$ -3.52$ -2.25$ -3.22$ -3.18
Diluted EPS
$ -20.94$ -3.52$ -2.25$ -3.22$ -3.18
Weighted Average Shares Outstanding
6.26M 24.87M 42.70M 39.86M 34.18M
Weighted Average Shares Outstanding (Diluted)
6.26M 24.87M 42.70M 39.86M 34.18M
Currency in USD

Aligos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis